GnRH agonist as novel luteal support: results of a randomized, parallel group, feasibility study using intranasal administration of buserelin*

Author： Pirard C. Donnez J. Loumaye E.

Publisher： Oxford University Press

ISSN： 1460-2350

Source： Human Reproduction, Vol.20, Iss.7, 2005-07, pp. : 1798-1804

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

GnRH agonist protocol administration in the luteal phase in ICSIET cycles stimulated with the long GnRH agonistprotocol: a randomized, controlled double blind study

By Ata B. Yakin K. Balaban B. Urman B.

Human Reproduction, Vol. 23, Iss. 3, 2008-03 ,pp. : 668-673

Oxford University Press

Access to resources Recommend Favorite

GnRH agonist (buserelin) or HCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study

By Engmann Lawrence Benadiva Claudio

Human Reproduction, Vol. 20, Iss. 11, 2005-11 ,pp. : 3258-3260

Oxford University Press

Access to resources Recommend Favorite

GnRH agonist as luteal phase support in assisted reproduction technique cycles: results of a pilot study

By Pirard C. Donnez J. Loumaye E.

Human Reproduction, Vol. 21, Iss. 7, 2006-07 ,pp. : 1894-1900

Oxford University Press

Access to resources Recommend Favorite

GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study

By Humaidan P.

Human Reproduction, Vol. 20, Iss. 5, 2005-05 ,pp. : 1213-1220

Oxford University Press

Access to resources Recommend Favorite

Reply: GnRH agonist (buserelin) or hCG for ovulation induction in gnRH antagonist IVF/ICSI cycles: a prospective randomized study

By Humaidan Peter

Human Reproduction, Vol. 20, Iss. 11, 2005-11 ,pp. : 3260-3260

Oxford University Press

Access to resources Recommend Favorite